tradingkey.logo

Neurosense Therapeutics Ltd

NRSN
View Detailed Chart

1.080USD

0.0000.00%
Close 08/01, 16:00ETQuotes delayed by 15 min
25.09MMarket Cap
LossP/E TTM

Neurosense Therapeutics Ltd

1.080

0.0000.00%
Intraday
1m
30m
1h
D
W
M
D

Today

-40.00%

5 Days

-46.80%

1 Month

-43.46%

6 Months

-8.47%

Year to Date

-10.00%

1 Year

+46.30%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 3 analysts
BUY
Current Rating
14.000
Target Price
1196.30%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

552
Total
5
Median
6
Average
Company name
Ratings
Analysts
Neurosense Therapeutics Ltd
NRSN
3
CRISPR Therapeutics AG
CRSP
29
Intellia Therapeutics Inc
NTLA
28
Ionis Pharmaceuticals Inc
IONS
27
Exact Sciences Corp
EXAS
27
IQVIA Holdings Inc
IQV
25
1
2
3
...
111

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

1m
15m
30m
1h
D
W
M
1m
15m
30m
D
Sell
Sell(10)
Neutral(0)
Buy(0)
Indicators
Sell(4)
Neutral(0)
Buy(0)
Indicators
Value
Direction
MACD(12,26,9)
-0.161
Sell
RSI(14)
22.618
Sell
STOCH(KDJ)(9,3,3)
16.840
Sell
ATR(14)
0.192
High Vlolatility
CCI(14)
-344.378
Oversold
Williams %R
92.727
Oversold
TRIX(12,20)
-0.410
Sell
StochRSI(14)
0.000
Oversold
Moving Average
Sell(6)
Neutral(0)
Buy(0)
Indicators
Value
Direction
MA5
1.700
Sell
MA10
1.847
Sell
MA20
1.947
Sell
MA50
1.945
Sell
MA100
1.507
Sell
MA200
1.317
Sell

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

NeuroSense Therapeutics Ltd is an Israel-based clinical-stage pharmaceutical company. The Company is active in field of drug development and treatment offers Amyotrophic Lateral Sclerosis (ALS) patients, as well as other neurodegenerative diseases. The Company's lead product candidate, PrimeC, is an oral formulation of a fixed dose combination composed of a specific ratio of drugs. In addition to PrimeC, the Company has initiated research and development efforts in Alzheimer's disease and Parkinson's disease
Ticker SymbolNRSN
CompanyNeurosense Therapeutics Ltd
CEOMr. Alon Ben-Noon
Websitehttps://www.neurosense-tx.com/
KeyAI